Governing board
BioWin is supported by an internationally renowned team of scientific advisors from industry and academia.
Board of directors
- President: Philippe Denoël, PhD, Head of External R&D (GSK)
- Vice-president SME: Hugues Bultot, CEO & Co-Founder (Univercells)
- Vice-president Academic: Professor Serge Schiffmann (ULB)
Representatives of large companies
- Philippe Denoël, PhD, Head of External R&D (GSK)
- Xavier Hormaechea, Head of EU Corporate Affairs (UCB)
- Christophe Allard, General Manager and Site Head (Cenexi)
- Jean-François Acquisto, VLife Sciences Business Unit Director (Eurogentec)
- Gaetane Metz, Chief Quality Officer (IBA)
SME representatives
- Hugues Bultot, CEO & Co-Founder (Univercells)
- Thibault Helleputte, Founder & CEO (DNAlytics)
- Jehan Liénart van Lidth de Jeude, CEO (Vesale Pharma)
- Melanie Mestdagt, PhD, CEO (EyeD Pharma)
- Javier Martinez, Co-Owner & Excecutive Director (Barré)
- Julie De Wever, PhD, Head (Bio.be/IPG)
University representatives
- Professor Serge Schiffmann (ULB)
- Professor Jean-Luc Balligand (UCL)
- Professor Michel Georges (ULiège)
- Professor Carine Michiels (UNamur)
- Professor Laurence Ris (UMons)
Representative of non-university research centers
- Bertrand Moinet (CER Marloie)